查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088641

人工器官與仿生市場：2026-2032年全球市場預測（依產品類型、技術、植入方法、材料類型、應用、最終用戶及通路分類）

Artificial Organ & Bionics Market by Product Type, Technology, Fixation Type, Material Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，人造器官和仿生學市場將成長至 521.1 億美元，複合年成長率為 9.43%。

主要市場統計數據
基準年 2025 277.2億美元
預計年份：2026年 301.9億美元
預測年份 2032 521.1億美元
複合年成長率 (%) 9.43%

人工器官和仿生技術正從維持生命的干預措施轉向數位化醫療技術平台，以恢復運動、感覺、循環、腎臟過濾和代謝調節功能。需求成長的結構性因素包括：移植需求與捐贈器官供應之間持續存在的缺口、人口老化、糖尿病和心血管疾病盛行率上升，以及創傷、中風、肢體缺失和慢性疾病後存活率的提高。

檢驗的公共衛生指標表明，人工器官、植入式仿生裝置、義肢和輔助技術的需求日益迫切。根據美國器官捐贈和移植網路（OPTN）統計，全美有超過10萬人正在等待器官移植，其中腎臟移植的需求量最大。世界衛生組織（WHO）報告稱，超過25億人需要至少一種輔助設備，而且由於人口老化和非傳染性疾病的增加，預計這項需求將進一步成長。這些現實促使臨床和政策制定者更加關注人工肌電義肢、心室輔助裝置、人工電子耳、義肢、肌電植入、視網膜植入物、仿生手和智慧外骨骼等設備。

人工器官和仿生學領域的變革性變化

先進生物材料、機器人技術、植入式電子裝置、3D列印、再生醫學、穿戴式感測器和互聯醫療的融合正在改變人工器官和仿生學領域。曾經主要依靠機械運作的設備如今配備了眾多感測器，由軟體控制，旨在實現遠端監測、預測性維護、個人化治療調整以及改善患者與設備的互動。

人工智慧的累積影響

人工智慧正整體成為人工器官和仿生系統領域的重要驅動力。在義肢領域，機器學習能夠提升肌電圖訊號中的意圖辨識能力，使仿生義肢更自然地回應使用者的動作。在心臟輔助設備和植入式監測領域，人工智慧驅動的分析與臨床檢驗的工作流程相結合，能夠及早識別幫浦性能的變化、心律不整的風險以及患者病情惡化的徵兆。

關鍵區域洞察

亞太地區是人工器官和仿生領域最具活力的需求中心之一，這主要得益於其龐大的患者群體、沉重的糖尿病負擔、不斷完善的醫院基礎設施，以及中國、日本、韓國、印度、澳洲和東南亞等國強大的醫療技術製造能力。預計日本和韓國將對先進的義肢、人工電子耳、手術機器人和復健技術有較高的接受度。同時，印度和東南亞國協的醫療保健系統正日益重視腎臟替代療法、輔助設備和肢體復健的可近性、在地化生產和普及。

主要群體分析

在東協市場，由於醫療體系的擴張和政府對醫療設備普及的重視，人工器官和仿生技術的重要性日益凸顯。然而，價格承受能力、保險覆蓋範圍、採購效率以及專家的可及性仍然是人工器官和仿生技術普及的關鍵因素。在海灣合作理事會（GCC）國家，對先進醫院、復健、移植相關護理和專業外科醫療體系的投資不斷增加，在公共醫療支出和醫療旅遊策略的支持下，對高階人工器官、植入式仿生技術、人工電子耳和義肢技術的需求也隨之成長。

主要國家的概況

美國在商業化路徑、創業融資、臨床試驗、移植相關創新、先進義肢、神經技術以及高風險人工器官的引進方面發揮主導作用。而加拿大則更注重公共資助的醫療路徑、醫療技術評估和實證應用。墨西哥和巴西是拉丁美洲的重要市場，這得益於其龐大的人口基數、不斷擴展的專業醫療網路以及日益成長的慢性病需求，但高階仿生系統的普及可能受到保險報銷差異和自付費用風險的限制。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床驗證的差異化優勢，而非功能繁多。最有效的義肢和仿生技術策略是將設備性能與可衡量的結果聯繫起來，例如改善行動能力、恢復聽力和視力、擺脫透析、縮短住院時間、提高生活品質、增強設備耐用性、降低併發症率以及降低整體醫療成本。

調查方法

本執行摘要基於來自檢驗的公共和機構來源的二手研究，包括器官移植登記處、衛生組織、監管機構、同行評審文獻、醫療設備指南文件、臨床試驗登記處以及公開的醫療保健基礎設施資訊。檢驗中常用的資訊來源包括世界衛生組織 (WHO)、美國食品藥物管理局(FDA)、器官捐贈和移植網路 (OPTN)、歐洲移植組織 (Eurotransplant)、國家衛生服務機構、國際疾病負擔資料庫以及醫療設備和軟體系統的認證標準和監管指南。

結論

人工器官和仿生學市場正朝著更數據主導、以患者為中心和以證據為基礎的階段轉變。這主要受器官短缺、慢性疾病負擔、人口老化、肢體缺失、感覺障礙、創傷倖存者以及全球對輔助科技的需求等結構性需求所驅動。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：人工器官與仿生學市場：依產品類型分類

  • 人工器官
    • 腎
    • 心
      • 全人工心臟
      • 心室輔助裝置
      • 人工心臟瓣膜
    • 肺
    • 肝
    • 胰臟
  • 仿生學
    • 視覺仿生學
    • 耳朵仿生學
    • 整形外科仿生學
    • 心臟仿生學
    • 外骨骼

第8章：人工器官與仿生市場：依技術分類

  • 機械的
  • 電子設備

第9章：人工器官與仿生市場：依固定方法分類

  • 嵌入式裝置
  • 穿戴式裝置

第10章：人工器官與仿生市場：依材料類型分類

  • 金屬
    • 鈦
    • 不銹鋼
  • 聚合物
  • 陶瓷
  • 生物材料
    • 膠原蛋白蛋白
    • 水凝膠型

第11章：人工器官與仿生市場：依應用領域分類

  • 器官衰竭的治療
  • 感覺功能的恢復
    • 聽力功能恢復
    • 視覺功能恢復
  • 運動功能恢復
  • 神經病變
  • 心血管疾病
  • 整形外科疾病

第12章：人工器官與仿生市場：依最終使用者分類

  • 門診手術中心
  • 居家照護
  • 醫院
  • 專科診所

第13章：人工器官與仿生市場：依通路分類

  • 線上
  • 離線

第14章：人工器官與仿生市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章：人工器官與仿生市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：人造器官與仿生市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Abbott Laboratories
  • Abiomed Inc.
  • ALung Technologies Inc.
  • Asahi Kasei Medical Co Ltd
  • AWAK Technologies Pte Ltd
  • Baxter International Inc.
  • Berlin Heart GmbH
  • BiVACOR Pty Ltd
  • Boston Scientific Corporation
  • CARMAT SA
  • Cochlear Limited
  • Cyberdyne Inc.
  • Edwards Lifesciences Corporation
  • Ekso Bionics Holdings Inc.
  • Fresenius Medical Care AG
  • Getinge AB
  • Jarvik Heart Inc.
  • Medtronic plc
  • Ottobock SE & Co KGaA
  • Second Sight Medical Products Inc.
  • Sonova Holding AG
  • SynCardia Systems LLC
  • Terumo Corporation
  • Zimmer Biomet Holdings Inc.
Product Code: MRR-A339DAEFA09B

The Artificial Organ & Bionics Market is projected to grow by USD 52.11 billion at a CAGR of 9.43% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 27.72 billion
Estimated Year [2026] USD 30.19 billion
Forecast Year [2032] USD 52.11 billion
CAGR (%) 9.43%

Artificial organs and bionics are moving from life-sustaining interventions to digitally enabled medical technology platforms that restore mobility, sensory function, circulation, renal filtration, and metabolic control. Demand is structurally supported by the persistent gap between transplant need and donor-organ availability, aging populations, rising diabetes and cardiovascular disease prevalence, and improved survivorship after trauma, stroke, limb loss, and chronic illness.

Verified public-health indicators reinforce the need for artificial organs, implantable bionics, neuroprosthetics, and assistive technologies. The U.S. Organ Procurement and Transplantation Network reports that more than 100,000 people are on the national transplant waiting list, with kidneys representing the largest share. The World Health Organization reports that more than 2.5 billion people need at least one assistive product, with this need expected to rise as populations age and noncommunicable diseases increase. These realities are accelerating clinical and policy attention on artificial kidneys, ventricular assist devices, cochlear implants, neuroprosthetics, myoelectric limbs, retinal implants, bionic hands, and smart exoskeletons.

Transformative Shifts in the Artificial Organ & Bionics Landscape

The artificial organ and bionics landscape is being reshaped by the convergence of advanced biomaterials, robotics, implantable electronics, 3D printing, regenerative medicine, wearable sensors, and connected care. Devices that were once primarily mechanical are increasingly sensor-rich, software-controlled, and designed for remote monitoring, predictive maintenance, personalized therapy adjustment, and improved patient-device interaction.

Regulatory expectations are also evolving across major healthcare systems. The U.S. Food and Drug Administration, European notified bodies operating under the EU Medical Device Regulation, and national health technology assessment bodies are placing stronger emphasis on clinical evidence, cybersecurity, usability engineering, post-market surveillance, and real-world performance. This is shifting competitive advantage toward developers that can combine clinical outcomes, patient experience, reimbursement evidence, manufacturing quality, and lifecycle data integrity.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical enabler across artificial organs and bionic systems. In prosthetics, machine learning can improve intent recognition from electromyography signals, helping bionic limbs respond more naturally to user movement. In cardiac assist devices and implantable monitoring ecosystems, AI-enabled analytics can support earlier identification of pump performance changes, arrhythmia risk, and patient deterioration signals when integrated with clinically validated workflows.

The cumulative impact of artificial intelligence is operational as well as clinical. AI supports patient selection, digital twin modeling, design optimization, imaging analysis, additive-manufacturing quality control, rehabilitation personalization, and post-market vigilance. However, successful deployment depends on validated datasets, explainability, bias mitigation, cybersecurity, human factors engineering, and alignment with medical-device software regulations, including FDA guidance on software functions and internationally recognized quality-management practices.

Key Regional Insights

Asia-Pacific is one of the most dynamic demand centers for artificial organs and bionics due to large patient populations, high diabetes burden, expanding hospital infrastructure, and domestic medtech manufacturing strength across China, Japan, South Korea, India, Australia, and Southeast Asia. Japan and South Korea show strong uptake potential in advanced prosthetics, cochlear implants, surgical robotics, and rehabilitation technologies, while India and ASEAN healthcare systems are increasingly focused on affordability, local production, and broader access to renal replacement technologies, assistive devices, and limb rehabilitation.

North America remains a global leader in high-acuity artificial organs, neuroprosthetics, ventricular assist devices, cochlear implants, and implantable bionics, supported by mature clinical trial networks, FDA regulatory pathways, venture financing, specialty care capacity, and established reimbursement channels. Europe benefits from strong clinical research, rehabilitation systems, organ-transplant infrastructure, and EU regulatory harmonization, although Medical Device Regulation transition requirements have increased evidence, documentation, and compliance expectations. Latin America shows rising need for renal, cardiac, auditory, and prosthetic solutions, with Brazil and Mexico acting as important access hubs. The Middle East is advancing through specialized hospitals, transplant programs, rehabilitation investment, and medical tourism strategies, while Africa presents substantial unmet need, with adoption closely tied to public procurement, workforce development, affordability, infrastructure availability, and nonprofit or donor-supported access models.

Key Group Insights

ASEAN markets are gaining relevance as healthcare capacity expands and governments prioritize medical-device access, yet affordability, reimbursement coverage, procurement efficiency, and specialist availability remain decisive for artificial organ and bionics adoption. GCC countries are investing in advanced hospitals, rehabilitation, transplant-related care, and specialty surgical capacity, creating opportunities for premium artificial organ, implantable bionics, cochlear implant, and prosthetic technologies supported by public health spending and medical tourism strategies.

The European Union is influential through the EU Medical Device Regulation, cross-border research funding, coordinated health data initiatives, and gradual health technology assessment convergence. BRICS countries combine large chronic disease burdens with growing domestic manufacturing ambitions, especially in China, India, and Brazil, while Russia and South Africa add distinct regional clinical and access dynamics. G7 markets remain central to premium innovation, reimbursement evidence, clinical validation, and regulatory precedent setting. NATO members' defense rehabilitation ecosystems continue to support advanced prosthetics, powered exoskeletons, osseointegration research, and trauma-related bionic innovation, particularly for injured service members and complex rehabilitation pathways.

Key Country Insights

The United States leads in commercialization pathways, venture funding, clinical trials, transplant-adjacent innovation, advanced prosthetics, neurotechnology, and high-acuity artificial organ adoption, while Canada emphasizes publicly funded care pathways, health technology assessment, and evidence-based adoption. Mexico and Brazil are important Latin American markets, supported by large populations, growing specialty care networks, and rising chronic disease needs, although reimbursement variability and out-of-pocket exposure can limit access to high-end bionic systems.

The United Kingdom, Germany, France, Italy, and Spain anchor European demand through national health systems, rehabilitation networks, specialist surgical capacity, and structured procurement processes; Germany is particularly strong in engineering-led prosthetics, orthotics, and medtech manufacturing. Russia maintains scientific and clinical capability in selected areas, but procurement constraints, technology-transfer limits, and supply-chain friction influence adoption. China is scaling domestic medtech production, hospital modernization, cochlear implantation, and advanced rehabilitation technologies, while India presents large unmet need and cost-sensitive adoption opportunities across renal replacement, prosthetics, and assistive devices. Japan and South Korea remain advanced robotics, implant, and rehabilitation technology markets with aging-population demand, and Australia benefits from strong cochlear implant expertise, rehabilitation services, clinical research infrastructure, and public-private care pathways.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated differentiation rather than feature proliferation. The strongest artificial organ and bionics strategies will link device performance to measurable outcomes such as mobility improvement, auditory or visual function gains, dialysis independence goals, hospitalization reduction, quality-of-life improvement, device longevity, lower complication rates, and reduced total cost of care.

Manufacturers and technology developers should build evidence packages early, including real-world data plans, cybersecurity documentation, health-economic models, usability validation, and patient-reported outcomes. Partnerships with transplant centers, rehabilitation clinics, dialysis providers, payers, veterans' health systems, academic hospitals, and public procurement bodies can shorten adoption cycles. Companies should also design for serviceability, inclusive ergonomics, interoperability, training efficiency, and regional affordability to address both premium innovation markets and access-oriented healthcare systems.

Research Methodology

This executive summary is developed using secondary research from verifiable public and institutional sources, including organ transplant registries, health agencies, regulatory bodies, peer-reviewed literature, medical-device guidance documents, clinical trial registries, and publicly available healthcare infrastructure information. Sources commonly referenced in validation include the World Health Organization, U.S. Food and Drug Administration, Organ Procurement and Transplantation Network, Eurotransplant, national health services, international disease-burden databases, and recognized standards or regulatory guidance for medical devices and software-enabled systems.

The methodology triangulates demand drivers, disease prevalence, transplant access indicators, technology adoption signals, regulatory developments, reimbursement considerations, manufacturing trends, clinical evidence requirements, and regional healthcare infrastructure. Insights are structured to support strategic decision-making for manufacturers, suppliers, investors, providers, policymakers, rehabilitation networks, and procurement stakeholders across the artificial organ and bionics ecosystem.

Conclusion

The artificial organ and bionics market is entering a more data-driven, patient-centered, and evidence-intensive phase. Structural demand is reinforced by transplant shortages, chronic disease burden, aging demographics, limb loss, sensory impairment, trauma survivorship, and the global need for assistive technologies.

Competitive leadership will depend on integrated capabilities across advanced materials, robotics, implantable electronics, AI-enabled monitoring, clinical validation, regulatory excellence, cybersecurity, and scalable manufacturing. Organizations that align innovation with affordability, measurable outcomes, serviceability, and regional access needs will be best positioned to strengthen adoption across healthcare systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Artificial Organ & Bionics Market, by Product Type

  • 7.1. Artificial Organs
    • 7.1.1. Kidney
    • 7.1.2. Heart
      • 7.1.2.1. Total Artificial Heart
      • 7.1.2.2. Ventricular Assist Devices
      • 7.1.2.3. Artificial Heart Valves
    • 7.1.3. Lungs
    • 7.1.4. Liver
    • 7.1.5. Pancreas
  • 7.2. Artificial Bionics
    • 7.2.1. Vision Bionics
    • 7.2.2. Ear Bionics
    • 7.2.3. Orthopedic Bionics
    • 7.2.4. Cardiac Bionics
    • 7.2.5. Exoskeletons

8. Artificial Organ & Bionics Market, by Technology

  • 8.1. Mechanical
  • 8.2. Electronic

9. Artificial Organ & Bionics Market, by Fixation Type

  • 9.1. Implantable Devices
  • 9.2. Wearable Devices

10. Artificial Organ & Bionics Market, by Material Type

  • 10.1. Metals
    • 10.1.1. Titanium
    • 10.1.2. Stainless Steel
  • 10.2. Polymers
  • 10.3. Ceramics
  • 10.4. Biomaterials
    • 10.4.1. Collagen-based
    • 10.4.2. Hydrogel-based

11. Artificial Organ & Bionics Market, by Application

  • 11.1. Organ Failure Treatment
  • 11.2. Sensory Restoration
    • 11.2.1. Hearing Restoration
    • 11.2.2. Vision Restoration
  • 11.3. Mobility Restoration
  • 11.4. Neurological Disorders
  • 11.5. Cardiovascular Disorders
  • 11.6. Orthopedic Disorders

12. Artificial Organ & Bionics Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Homecare
  • 12.3. Hospitals
  • 12.4. Specialty Clinics

13. Artificial Organ & Bionics Market, by Distribution Channel

  • 13.1. Online
  • 13.2. Offline

14. Artificial Organ & Bionics Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Artificial Organ & Bionics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Artificial Organ & Bionics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Abbott Laboratories
  • 18.2. Abiomed Inc.
  • 18.3. ALung Technologies Inc.
  • 18.4. Asahi Kasei Medical Co Ltd
  • 18.5. AWAK Technologies Pte Ltd
  • 18.6. Baxter International Inc.
  • 18.7. Berlin Heart GmbH
  • 18.8. BiVACOR Pty Ltd
  • 18.9. Boston Scientific Corporation
  • 18.10. CARMAT SA
  • 18.11. Cochlear Limited
  • 18.12. Cyberdyne Inc.
  • 18.13. Edwards Lifesciences Corporation
  • 18.14. Ekso Bionics Holdings Inc.
  • 18.15. Fresenius Medical Care AG
  • 18.16. Getinge AB
  • 18.17. Jarvik Heart Inc.
  • 18.18. Medtronic plc
  • 18.19. Ottobock SE & Co KGaA
  • 18.20. Second Sight Medical Products Inc.
  • 18.21. Sonova Holding AG
  • 18.22. SynCardia Systems LLC
  • 18.23. Terumo Corporation
  • 18.24. Zimmer Biomet Holdings Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL KIDNEY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL KIDNEY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HEART MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HEART MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HEART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL TOTAL ARTIFICIAL HEART MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL TOTAL ARTIFICIAL HEART MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL TOTAL ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VENTRICULAR ASSIST DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VENTRICULAR ASSIST DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VENTRICULAR ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL HEART VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL HEART VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LUNGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LUNGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LUNGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LIVER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LIVER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LIVER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PANCREAS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PANCREAS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PANCREAS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL BIONICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL BIONICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL BIONICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VISION BIONICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VISION BIONICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VISION BIONICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL EAR BIONICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL EAR BIONICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL EAR BIONICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ORTHOPEDIC BIONICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ORTHOPEDIC BIONICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ORTHOPEDIC BIONICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CARDIAC BIONICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CARDIAC BIONICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CARDIAC BIONICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL EXOSKELETONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL EXOSKELETONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL EXOSKELETONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MECHANICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MECHANICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MECHANICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ELECTRONIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ELECTRONIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ELECTRONIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL WEARABLE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL WEARABLE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL WEARABLE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL METALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL METALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL METALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL TITANIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL TITANIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL TITANIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL STAINLESS STEEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL STAINLESS STEEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL STAINLESS STEEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL POLYMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL POLYMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL POLYMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CERAMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CERAMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CERAMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOMATERIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOMATERIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL COLLAGEN-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL COLLAGEN-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL COLLAGEN-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HYDROGEL-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HYDROGEL-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HYDROGEL-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ORGAN FAILURE TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ORGAN FAILURE TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ORGAN FAILURE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SENSORY RESTORATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SENSORY RESTORATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SENSORY RESTORATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HEARING RESTORATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HEARING RESTORATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HEARING RESTORATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL VISION RESTORATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL VISION RESTORATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL VISION RESTORATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MOBILITY RESTORATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MOBILITY RESTORATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MOBILITY RESTORATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CARDIOVASCULAR DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CARDIOVASCULAR DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CARDIOVASCULAR DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HOMECARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL HOMECARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL HOMECARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 232. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2018-2032 (USD MILLION)
  • TABLE 235. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2018-2032 (USD MILLION)
  • TABLE 236. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2032 (USD MILLION)
  • TABLE 237. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 241. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 242. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2018-2032 (USD MILLION)
  • TABLE 244. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. GCC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 274. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2018-2032 (USD MILLION)
  • TABLE 277. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2018-2032 (USD MILLION)
  • TABLE 278. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2032 (USD MILLION)
  • TABLE 279. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 280. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 283. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 284. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 285. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2018-2032 (USD MILLION)
  • TABLE 286. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. G7 ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 288. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 289. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2018-2032 (USD MILLION)
  • TABLE 291. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2018-2032 (USD MILLION)
  • TABLE 292. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2032 (USD MILLION)
  • TABLE 293. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 297. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 298. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 299. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2018-2032 (USD MILLION)
  • TABLE 300. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 301. NATO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 302. GLOBAL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 317. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 318. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2018-2032 (USD MILLION)
  • TABLE 320. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2018-2032 (USD MILLION)
  • TABLE 321. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2032 (USD MILLION)
  • TABLE 322. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 323. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 324. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 326. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 327. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 328. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2018-2032 (USD MILLION)
  • TABLE 329. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 330. CANADA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 331. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 332. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 333. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2018-2032 (USD MILLION)
  • TABLE 334. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2018-2032 (USD MILLION)
  • TABLE 335. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2032 (USD MILLION)
  • TABLE 336. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 337. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 338. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 339. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 340. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY BIOMATERIALS, 2018-2032 (USD MILLION)
  • TABLE 341. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 342. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY SENSORY RESTORATION, 2018-2032 (USD MILLION)
  • TABLE 343. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 344. MEXICO ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 345. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 346. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 347. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL ORGANS, 2018-2032 (USD MILLION)
  • TABLE 348. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY HEART, 2018-2032 (USD MILLION)
  • TABLE 349. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY ARTIFICIAL BIONICS, 2018-2032 (USD MILLION)
  • TABLE 350. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 351. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY FIXATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 352. BRAZIL ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY MATERIAL TYPE, 2018-20